SeraCare Life Sciences Announces Renewal of National Institutes of Health Contract to Support Research (SRLS)

SeraCare Life Sciences SRLS announced today that the National Heart, Lung, and Blood Institute of the National Institutes of Health has awarded a new contract to SeraCare, replacing the current contract which expired on April 30, 2011. Under this contract, SeraCare, at the direction of the NHLBI, will advise on proper collection, processing and storage for biorepository collections. SeraCare will also continue to acquire, store and distribute biospecimens to the scientific community for use in research related to transfusion-transmitted diseases and a variety of other disorders of the blood and the cardiovascular and respiratory systems. The contract is valued at $17.6 million over a five-year term, for an average of $3.5 million per year, if all options are exercised by the NHLBI.